Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.

作者: Anna‐Marie Fairhurst , Amy E. Wandstrat , Edward K. Wakeland

DOI: 10.1016/S0065-2776(06)92001-X

关键词:

摘要: Abstract Systemic lupus erythematosus (SLE) is a complex polygenic autoimmune disease characterized by the presence of anti‐nuclear autoantibodies (ANAs) that are often detectable years prior to onset clinical disease. The associated with chronic activation immune system, most severe forms progressing inflammatory damage can impact multiple organ systems in afflicted individuals. Current therapeutic strategies poorly control manifestations and generally immunosuppressive. Recent studies human patient populations animal models have elements innate system abnormalities immature B lymphocyte receptor repertoires initiation. A variety cytokines, notably type I interferons, play important roles pathogenesis effector mechanisms. genetic basis for susceptibility complex, analyses humans mice identified loci, several which located genomic regions syntenic between mice. complexities interactions mediate been investigated murine model characterizing progressive development strains expressing various combinations alleles. These indicate epistasis dramatically support feasibility identifying molecular pathways suppress progression without completely impairing normal function.

参考文章(420)
J L Funk, L A Cordaro, H Wei, J B Benjamin, D E Yocum, Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. Journal of Clinical Investigation. ,vol. 101, pp. 1362- 1372 ,(1998) , 10.1172/JCI728
ME Reff, K Carner, KS Chambers, PC Chinn, JE Leonard, R Raab, RA Newman, N Hanna, DR Anderson, Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood. ,vol. 83, pp. 435- 445 ,(1994) , 10.1182/BLOOD.V83.2.435.435
Hochberg Mc, Felts Wr, Lawrence Rc, Shulman Le, Medsger Ta, Kelsey Jl, McDuffie Fc, Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. The Journal of Rheumatology. ,vol. 16, pp. 427- 441 ,(1989)
Wilder Rl, Pando Ja, Crofford Lj, Gourley Mf, Hormonal supplementation as treatment for cyclical rashes in patients with systemic lupus erythematosus. The Journal of Rheumatology. ,vol. 22, pp. 2159- 2162 ,(1995)
L. H. Glimcher, F. Takei, A. M. Jevnikar, V. E. Kelley, R. P. Wuthrich, Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. American Journal of Pathology. ,vol. 136, pp. 441- 450 ,(1990)
E. N. Anderson, Hudson et al. Journal of California Anthropology, The. ,vol. 4, ,(1977)
Eric S. Sobel, Laurence Morel, Raquel Baert, Chandra Mohan, Joel Schiffenbauer, Edward K. Wakeland, Genetic Dissection of Systemic Lupus Erythematosus Pathogenesis: Evidence for Functional Expression of Sle3/5 by Non-T Cells The Journal of Immunology. ,vol. 169, pp. 4025- 4032 ,(2002) , 10.4049/JIMMUNOL.169.7.4025
S.R. Block, J.B. Winfield, M.D. Lockshin, W.A. D'Angelo, C.L. Christian, Studies of twins with systemic lupus erythematosus: A review of the literature and presentation of 12 additional sets The American Journal of Medicine. ,vol. 59, pp. 533- 552 ,(1975) , 10.1016/0002-9343(75)90261-2
H. G. Kunkel, E. M. Tan, Characteristics of a Soluble Nuclear Antigen Precipitating with Sera of Patients with Systemic Lupus Erythematosus Journal of Immunology. ,vol. 96, pp. 464- 471 ,(1966)